Biography:
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, Suchkov maintained his PhD as a PhD student of Sechenov University and Institute of Medical Enzymology. In 2001, Suchkov maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1989 through 1995, a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004 - a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996.
At present, Dr Sergey Suchkov, MD, PhD, is:
● Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Moscow, Russia
● R&D Director, InMedStar, Russia-UAE
● Senior Scientific Advisor of China Hong Kong Innovation International Business Association, Hong Kong
● Member, The Russian Academy of Natural Sciences, Moscow, Russia
● Member, New York Academy of Sciences, USA
● American Chemical Society (ACS), USA;
● American Heart Association (AHA), USA;
● European Association for Medical Education (AMEE), Dundee, UK;
● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU;
● ARVO (American Association for Research in Vision and Ophthalmology);
● ISER (International Society for Eye Research);
● Personalized Medicine Coalition (PMC), Washington, DC, USA



Personalized oncology via precision oncology strategy for cancer care team: Developing targeted cancer therapy & advancing personalized cancer care
Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure national biosafety: to get cancer treated or cured?
Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety